Thus, we generated mouse models of pancreatic cancer by inactivation of Palb2, Brca1 or Brca2 genes specifically in the pancreas and compared the resulting tumor latencies, histo-pathologies, anticancer drug responses and immune cell infiltration. This evidence concerns the gene BRCA1 and familial pancreatic carcinoma.